| 发明名称 |
NITROGENATED 5-MEMBERED HETEROCYCLIC COMPOUND |
| 摘要 |
<p>The purpose of the present invention is to provide a glucokinase activator which is useful as a pharmaceutical agent such as agents for the prophylaxis or treatment of diabetes, obesity and the like, and the like. The present invention is a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof.</p> |
| 申请公布号 |
EP2266983(A1) |
申请公布日期 |
2010.12.29 |
| 申请号 |
EP20090732181 |
申请日期 |
2009.04.15 |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
YASUMA, TSUNEO;UJIKAWA, OSAMU |
| 分类号 |
C07D417/14;A61K31/427;A61K31/4439;A61P3/00;A61P3/04;A61P3/10;C07D405/14;C07D471/04 |
主分类号 |
C07D417/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
